Universal Biosensors, Inc. (ASX:UBI)
0.0210
+0.0010 (5.00%)
Aug 5, 2025, 4:10 PM AEST
Marathon Oil Revenue
Universal Biosensors had revenue of 1.55M AUD in the quarter ending March 31, 2025, with 5.79% growth. This brings the company's revenue in the last twelve months to 6.37M, down -6.45% year-over-year. In the year 2024, Universal Biosensors had annual revenue of 6.28M, down -5.28%.
Revenue (ttm)
6.37M
Revenue Growth
-6.45%
P/S Ratio
1.05
Revenue / Employee
78.30K
Employees
76
Market Cap
6.26M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.28M | -350.10K | -5.28% |
Dec 31, 2023 | 6.63M | 2.11M | 46.58% |
Dec 31, 2022 | 4.52M | -1.25M | -21.68% |
Dec 31, 2021 | 5.78M | 2.58M | 80.41% |
Dec 31, 2020 | 3.20M | -3.69M | -53.57% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 783.21M |
Ansell | 3.00B |
Mesoblast | 9.16M |